Pelotonia Impact

Supporting seven areas of research

Pelotonia believes in moving fast and funding researchers and projects early. It’s a pace perfectly suited for new ideas and exciting potential. Take a closer look at how Pelotonia dollars are used to accelerate innovative cancer research at the OSUCCC – James and to help us achieve our One Goal.

Seven categories of investment. Endless possibilities. The funds raised by Pelotonia are divided into strategic groups to invest in developing research talent and fueling innovation across a wide spectrum of cancer types, demographics, and geographies.

Pelotonia-Funded research areas

Percentages reflect Pelotonia funding through FY23

01
researcher
development
37%
Pelotonia funds are used to recruit top scientists to Ohio State, helping them establish research labs and continue their innovative cancer research quickly, often leading to further external funding.
02
strategic
research
investments
26%
These funds provide seed money for new and innovative research ideas, accelerating cancer research projects that might otherwise go unfunded, leading to groundbreaking discoveries.
03
idea
grants
12%
Pelotonia supports early-stage research through Idea Grants, enabling researchers to explore high-risk, high-reward cancer studies that can yield additional external funding and foster breakthrough advancements in cancer treatment.
04
Pelotonia
Scholars
Program
9%
The program invests in training the next generation of cancer researchers by offering scholarships to undergraduate, graduate, and postdoctoral students, as well as medical students, from a variety of fields.
05
Pelotonia
Institute for
Immuno-Oncology
(PIIO)
7%
This institute, launched with Pelotonia funding, focuses on pioneering immunotherapy treatments that harness the body’s immune system to fight cancer, positioning it as the future frontier in cancer care.
06
Instruments of
Discovery
6%
These funds provide researchers with cutting-edge equipment, such as advanced screening technologies and cell-sorting instruments, essential for driving innovation in cancer research and treatment.
07
statewide
initiatives
3%
Investment in creating better outcomes for some of the most common cancer types through prevention and early detection methods to save and extend lives across the state of Ohio.

Impact of Pelotonia Investment Across Cancer Research

Recruited 290+ scientists to the OSUCCC – James with Pelotonia support since 2010

2,300+ treatments delivered and 100+ patients treated from six states since Proton Therapy Center opened in 2023

Awarded 221 Pelotonia-funded Idea Grants worth $31.25 million since 2010

11 new Pelotonia-funded Idea Grants totaling $1.4 million in 2024

The Pelotonia Scholars program has awarded 712 scholarships to students from 53 countries and 36 U.S. states since 2010

32 Pelotonia Scholars were awarded 32 scholarships in 2024, including 13 undergraduate students, 14 graduate students, 3 postdoctoral researchers, and 2 medical students

254 immunotherapy clinical trials launched at the PIIO since 2019

124 PIIO members awarded $43 million in annual grant funding ($25M from NCI) since 2019

1,450+ peer-reviewed articles published through the PIIO members

$488,000 invested in 2024 for the purchase of sophisticated equipment for some of the cancer program's Shared Resources

4 statewide initiatives in Ohio funded by Pelotonia, including "Turning the Page on Breast Cancer"

DAVID E. COHN, MD, MBA | COO, OSUCCC – JAMES

Raising over $300 million through Pelotonia is remarkable. We couldn’t do all that we’re doing to create a cancer-free world without the support we receive from the community.”

Community Inspires Impact

2024 impact report

This annual Impact Report is a collaboration between Pelotonia and the OSUCCC – James. In this report, explore highlights from community events and innovative initiatives which inspire the philanthropy accelerating critical funds for advancements in cancer research. 

Funding Partners

Thanks to our generous funding partners

100% of every participant-raised dollar goes to innovative cancer research at the OSUCCC – James.